Global Fruquintinib Supply, Demand and Key Producers, 2026-2032
The global Fruquintinib market size is expected to reach $ 1379 million by 2032, rising at a market growth of 14.6% CAGR during the forecast period (2026-2032).
In 2025, global production of fruquintinib reached approximately 810,000 units.Fruquintinib is an oral small-molecule highly selective vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor, primarily used for the treatment of various solid tumors, with demonstrated efficacy particularly in metastatic colorectal cancer. It exerts its anti-tumor effects by selectively inhibiting VEGFR-1, VEGFR-2, and VEGFR-3 signaling pathways, thereby blocking angiogenesis and suppressing tumor growth and metastasis. Fruquintinib is characterized by high target selectivity, convenient oral administration, and good tolerability, making it clinically valuable in the treatment of advanced cancers, especially in later-line therapy settings.
Fruquintinib, as a highly selective VEGFR tyrosine kinase inhibitor, holds an important position in the oncology targeted therapy market, particularly demonstrating strong competitiveness in the later-line treatment of metastatic colorectal cancer. With the continuous rise in cancer incidence and the widespread adoption of precision medicine, the demand for anti-angiogenic therapies continues to grow, providing a stable market foundation for this drug. From a competitive landscape perspective, anti-angiogenic monoclonal antibodies such as Bevacizumab and small-molecule multi-target TKIs such as Regorafenib dominate the market. However, fruquintinib, with its high selectivity, favorable safety profile, and clear clinical benefits, has established differentiated advantages in later-line treatment settings. On the policy side, its inclusion in the national reimbursement drug list helps improve patient accessibility and promote market expansion, although volume-based procurement and healthcare cost-control policies continue to exert downward pressure on pricing. From a competitive standpoint, the emergence of various anti-angiogenic therapies and combination regimens with immunotherapy from both domestic and international players is intensifying market competition. Therefore, the future market performance of fruquintinib will depend on its progress in expanding indications (such as gastric cancer and lung cancer), developing combination strategies, and accumulating real-world evidence, as well as its overall competitive balance in terms of efficacy, safety, and cost.
This report studies the global Fruquintinib production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Fruquintinib and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Fruquintinib that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Fruquintinib total production and demand, 2021-2032, (Units)
Global Fruquintinib total production value, 2021-2032, (USD Million)
Global Fruquintinib production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Fruquintinib consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Fruquintinib domestic production, consumption, key domestic manufacturers and share
Global Fruquintinib production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Fruquintinib production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Fruquintinib production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Fruquintinib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hutchison China MediTech Limited, Takeda Pharmaceutical Company Limited, Sichuan Qingmu Pharmaceutical, Shanghai Boyi Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Fruquintinib market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Fruquintinib Market, By Region:
1. How big is the global Fruquintinib market?
2. What is the demand of the global Fruquintinib market?
3. What is the year over year growth of the global Fruquintinib market?
4. What is the production and production value of the global Fruquintinib market?
5. Who are the key producers in the global Fruquintinib market?
6. What are the growth factors driving the market demand?
In 2025, global production of fruquintinib reached approximately 810,000 units.Fruquintinib is an oral small-molecule highly selective vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor, primarily used for the treatment of various solid tumors, with demonstrated efficacy particularly in metastatic colorectal cancer. It exerts its anti-tumor effects by selectively inhibiting VEGFR-1, VEGFR-2, and VEGFR-3 signaling pathways, thereby blocking angiogenesis and suppressing tumor growth and metastasis. Fruquintinib is characterized by high target selectivity, convenient oral administration, and good tolerability, making it clinically valuable in the treatment of advanced cancers, especially in later-line therapy settings.
Fruquintinib, as a highly selective VEGFR tyrosine kinase inhibitor, holds an important position in the oncology targeted therapy market, particularly demonstrating strong competitiveness in the later-line treatment of metastatic colorectal cancer. With the continuous rise in cancer incidence and the widespread adoption of precision medicine, the demand for anti-angiogenic therapies continues to grow, providing a stable market foundation for this drug. From a competitive landscape perspective, anti-angiogenic monoclonal antibodies such as Bevacizumab and small-molecule multi-target TKIs such as Regorafenib dominate the market. However, fruquintinib, with its high selectivity, favorable safety profile, and clear clinical benefits, has established differentiated advantages in later-line treatment settings. On the policy side, its inclusion in the national reimbursement drug list helps improve patient accessibility and promote market expansion, although volume-based procurement and healthcare cost-control policies continue to exert downward pressure on pricing. From a competitive standpoint, the emergence of various anti-angiogenic therapies and combination regimens with immunotherapy from both domestic and international players is intensifying market competition. Therefore, the future market performance of fruquintinib will depend on its progress in expanding indications (such as gastric cancer and lung cancer), developing combination strategies, and accumulating real-world evidence, as well as its overall competitive balance in terms of efficacy, safety, and cost.
This report studies the global Fruquintinib production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Fruquintinib and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Fruquintinib that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Fruquintinib total production and demand, 2021-2032, (Units)
Global Fruquintinib total production value, 2021-2032, (USD Million)
Global Fruquintinib production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Fruquintinib consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Fruquintinib domestic production, consumption, key domestic manufacturers and share
Global Fruquintinib production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Fruquintinib production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Fruquintinib production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Fruquintinib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hutchison China MediTech Limited, Takeda Pharmaceutical Company Limited, Sichuan Qingmu Pharmaceutical, Shanghai Boyi Chemical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Fruquintinib market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Fruquintinib Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 1 mg capsule
- 5 mg capsule
- Hospital
- Retail
- Online
- Metastatic Colorectal Cancer (mCRC)
- Inhibit Tumor Angiogenesis
- Others
- Hutchison China MediTech Limited
- Takeda Pharmaceutical Company Limited
- Sichuan Qingmu Pharmaceutical
- Shanghai Boyi Chemical
1. How big is the global Fruquintinib market?
2. What is the demand of the global Fruquintinib market?
3. What is the year over year growth of the global Fruquintinib market?
4. What is the production and production value of the global Fruquintinib market?
5. Who are the key producers in the global Fruquintinib market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Fruquintinib Introduction
1.2 World Fruquintinib Supply & Forecast
1.2.1 World Fruquintinib Production Value (2021 & 2025 & 2032)
1.2.2 World Fruquintinib Production (2021-2032)
1.2.3 World Fruquintinib Pricing Trends (2021-2032)
1.3 World Fruquintinib Production by Region (Based on Production Site)
1.3.1 World Fruquintinib Production Value by Region (2021-2032)
1.3.2 World Fruquintinib Production by Region (2021-2032)
1.3.3 World Fruquintinib Average Price by Region (2021-2032)
1.3.4 North America Fruquintinib Production (2021-2032)
1.3.5 Europe Fruquintinib Production (2021-2032)
1.3.6 China Fruquintinib Production (2021-2032)
1.3.7 Japan Fruquintinib Production (2021-2032)
1.3.8 India Fruquintinib Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Fruquintinib Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Fruquintinib Major Market Trends
2 DEMAND SUMMARY
2.1 World Fruquintinib Demand (2021-2032)
2.2 World Fruquintinib Consumption by Region
2.2.1 World Fruquintinib Consumption by Region (2021-2026)
2.2.2 World Fruquintinib Consumption Forecast by Region (2027-2032)
2.3 United States Fruquintinib Consumption (2021-2032)
2.4 China Fruquintinib Consumption (2021-2032)
2.5 Europe Fruquintinib Consumption (2021-2032)
2.6 Japan Fruquintinib Consumption (2021-2032)
2.7 South Korea Fruquintinib Consumption (2021-2032)
2.8 ASEAN Fruquintinib Consumption (2021-2032)
2.9 India Fruquintinib Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Fruquintinib Production Value by Manufacturer (2021-2026)
3.2 World Fruquintinib Production by Manufacturer (2021-2026)
3.3 World Fruquintinib Average Price by Manufacturer (2021-2026)
3.4 Fruquintinib Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Fruquintinib Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Fruquintinib in 2025
3.5.3 Global Concentration Ratios (CR8) for Fruquintinib in 2025
3.6 Fruquintinib Market: Overall Company Footprint Analysis
3.6.1 Fruquintinib Market: Region Footprint
3.6.2 Fruquintinib Market: Company Product Type Footprint
3.6.3 Fruquintinib Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Fruquintinib Production Value Comparison
4.1.1 United States VS China: Fruquintinib Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Fruquintinib Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Fruquintinib Production Comparison
4.2.1 United States VS China: Fruquintinib Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Fruquintinib Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Fruquintinib Consumption Comparison
4.3.1 United States VS China: Fruquintinib Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Fruquintinib Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Fruquintinib Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Fruquintinib Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Fruquintinib Production Value (2021-2026)
4.4.3 United States Based Manufacturers Fruquintinib Production (2021-2026)
4.5 China Based Fruquintinib Manufacturers and Market Share
4.5.1 China Based Fruquintinib Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Fruquintinib Production Value (2021-2026)
4.5.3 China Based Manufacturers Fruquintinib Production (2021-2026)
4.6 Rest of World Based Fruquintinib Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Fruquintinib Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Fruquintinib Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Fruquintinib Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Fruquintinib Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 1 mg capsule
5.2.2 5 mg capsule
5.3 Market Segment by Type
5.3.1 World Fruquintinib Production by Type (2021-2032)
5.3.2 World Fruquintinib Production Value by Type (2021-2032)
5.3.3 World Fruquintinib Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SALES CHANNELS
6.1 World Fruquintinib Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sales Channels
6.2.1 Hospital
6.2.2 Retail
6.2.3 Online
6.3 Market Segment by Sales Channels
6.3.1 World Fruquintinib Production by Sales Channels (2021-2032)
6.3.2 World Fruquintinib Production Value by Sales Channels (2021-2032)
6.3.3 World Fruquintinib Average Price by Sales Channels (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Fruquintinib Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Metastatic Colorectal Cancer (mCRC)
7.2.2 Inhibit Tumor Angiogenesis
7.2.3 Others
7.3 Market Segment by Application
7.3.1 World Fruquintinib Production by Application (2021-2032)
7.3.2 World Fruquintinib Production Value by Application (2021-2032)
7.3.3 World Fruquintinib Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Hutchison China MediTech Limited
8.1.1 Hutchison China MediTech Limited Details
8.1.2 Hutchison China MediTech Limited Major Business
8.1.3 Hutchison China MediTech Limited Fruquintinib Product and Services
8.1.4 Hutchison China MediTech Limited Fruquintinib Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Hutchison China MediTech Limited Recent Developments/Updates
8.1.6 Hutchison China MediTech Limited Competitive Strengths & Weaknesses
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Takeda Pharmaceutical Company Limited Details
8.2.2 Takeda Pharmaceutical Company Limited Major Business
8.2.3 Takeda Pharmaceutical Company Limited Fruquintinib Product and Services
8.2.4 Takeda Pharmaceutical Company Limited Fruquintinib Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
8.2.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
8.3 Sichuan Qingmu Pharmaceutical
8.3.1 Sichuan Qingmu Pharmaceutical Details
8.3.2 Sichuan Qingmu Pharmaceutical Major Business
8.3.3 Sichuan Qingmu Pharmaceutical Fruquintinib Product and Services
8.3.4 Sichuan Qingmu Pharmaceutical Fruquintinib Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Sichuan Qingmu Pharmaceutical Recent Developments/Updates
8.3.6 Sichuan Qingmu Pharmaceutical Competitive Strengths & Weaknesses
8.4 Shanghai Boyi Chemical
8.4.1 Shanghai Boyi Chemical Details
8.4.2 Shanghai Boyi Chemical Major Business
8.4.3 Shanghai Boyi Chemical Fruquintinib Product and Services
8.4.4 Shanghai Boyi Chemical Fruquintinib Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Shanghai Boyi Chemical Recent Developments/Updates
8.4.6 Shanghai Boyi Chemical Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Fruquintinib Industry Chain
9.2 Fruquintinib Upstream Analysis
9.2.1 Fruquintinib Core Raw Materials
9.2.2 Main Manufacturers of Fruquintinib Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Fruquintinib Production Mode
9.6 Fruquintinib Procurement Model
9.7 Fruquintinib Industry Sales Model and Sales Channels
9.7.1 Fruquintinib Sales Model
9.7.2 Fruquintinib Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Fruquintinib Introduction
1.2 World Fruquintinib Supply & Forecast
1.2.1 World Fruquintinib Production Value (2021 & 2025 & 2032)
1.2.2 World Fruquintinib Production (2021-2032)
1.2.3 World Fruquintinib Pricing Trends (2021-2032)
1.3 World Fruquintinib Production by Region (Based on Production Site)
1.3.1 World Fruquintinib Production Value by Region (2021-2032)
1.3.2 World Fruquintinib Production by Region (2021-2032)
1.3.3 World Fruquintinib Average Price by Region (2021-2032)
1.3.4 North America Fruquintinib Production (2021-2032)
1.3.5 Europe Fruquintinib Production (2021-2032)
1.3.6 China Fruquintinib Production (2021-2032)
1.3.7 Japan Fruquintinib Production (2021-2032)
1.3.8 India Fruquintinib Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Fruquintinib Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Fruquintinib Major Market Trends
2 DEMAND SUMMARY
2.1 World Fruquintinib Demand (2021-2032)
2.2 World Fruquintinib Consumption by Region
2.2.1 World Fruquintinib Consumption by Region (2021-2026)
2.2.2 World Fruquintinib Consumption Forecast by Region (2027-2032)
2.3 United States Fruquintinib Consumption (2021-2032)
2.4 China Fruquintinib Consumption (2021-2032)
2.5 Europe Fruquintinib Consumption (2021-2032)
2.6 Japan Fruquintinib Consumption (2021-2032)
2.7 South Korea Fruquintinib Consumption (2021-2032)
2.8 ASEAN Fruquintinib Consumption (2021-2032)
2.9 India Fruquintinib Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Fruquintinib Production Value by Manufacturer (2021-2026)
3.2 World Fruquintinib Production by Manufacturer (2021-2026)
3.3 World Fruquintinib Average Price by Manufacturer (2021-2026)
3.4 Fruquintinib Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Fruquintinib Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Fruquintinib in 2025
3.5.3 Global Concentration Ratios (CR8) for Fruquintinib in 2025
3.6 Fruquintinib Market: Overall Company Footprint Analysis
3.6.1 Fruquintinib Market: Region Footprint
3.6.2 Fruquintinib Market: Company Product Type Footprint
3.6.3 Fruquintinib Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Fruquintinib Production Value Comparison
4.1.1 United States VS China: Fruquintinib Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Fruquintinib Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Fruquintinib Production Comparison
4.2.1 United States VS China: Fruquintinib Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Fruquintinib Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Fruquintinib Consumption Comparison
4.3.1 United States VS China: Fruquintinib Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Fruquintinib Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Fruquintinib Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Fruquintinib Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Fruquintinib Production Value (2021-2026)
4.4.3 United States Based Manufacturers Fruquintinib Production (2021-2026)
4.5 China Based Fruquintinib Manufacturers and Market Share
4.5.1 China Based Fruquintinib Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Fruquintinib Production Value (2021-2026)
4.5.3 China Based Manufacturers Fruquintinib Production (2021-2026)
4.6 Rest of World Based Fruquintinib Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Fruquintinib Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Fruquintinib Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Fruquintinib Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Fruquintinib Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 1 mg capsule
5.2.2 5 mg capsule
5.3 Market Segment by Type
5.3.1 World Fruquintinib Production by Type (2021-2032)
5.3.2 World Fruquintinib Production Value by Type (2021-2032)
5.3.3 World Fruquintinib Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY SALES CHANNELS
6.1 World Fruquintinib Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Sales Channels
6.2.1 Hospital
6.2.2 Retail
6.2.3 Online
6.3 Market Segment by Sales Channels
6.3.1 World Fruquintinib Production by Sales Channels (2021-2032)
6.3.2 World Fruquintinib Production Value by Sales Channels (2021-2032)
6.3.3 World Fruquintinib Average Price by Sales Channels (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Fruquintinib Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Metastatic Colorectal Cancer (mCRC)
7.2.2 Inhibit Tumor Angiogenesis
7.2.3 Others
7.3 Market Segment by Application
7.3.1 World Fruquintinib Production by Application (2021-2032)
7.3.2 World Fruquintinib Production Value by Application (2021-2032)
7.3.3 World Fruquintinib Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Hutchison China MediTech Limited
8.1.1 Hutchison China MediTech Limited Details
8.1.2 Hutchison China MediTech Limited Major Business
8.1.3 Hutchison China MediTech Limited Fruquintinib Product and Services
8.1.4 Hutchison China MediTech Limited Fruquintinib Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Hutchison China MediTech Limited Recent Developments/Updates
8.1.6 Hutchison China MediTech Limited Competitive Strengths & Weaknesses
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Takeda Pharmaceutical Company Limited Details
8.2.2 Takeda Pharmaceutical Company Limited Major Business
8.2.3 Takeda Pharmaceutical Company Limited Fruquintinib Product and Services
8.2.4 Takeda Pharmaceutical Company Limited Fruquintinib Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
8.2.6 Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
8.3 Sichuan Qingmu Pharmaceutical
8.3.1 Sichuan Qingmu Pharmaceutical Details
8.3.2 Sichuan Qingmu Pharmaceutical Major Business
8.3.3 Sichuan Qingmu Pharmaceutical Fruquintinib Product and Services
8.3.4 Sichuan Qingmu Pharmaceutical Fruquintinib Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Sichuan Qingmu Pharmaceutical Recent Developments/Updates
8.3.6 Sichuan Qingmu Pharmaceutical Competitive Strengths & Weaknesses
8.4 Shanghai Boyi Chemical
8.4.1 Shanghai Boyi Chemical Details
8.4.2 Shanghai Boyi Chemical Major Business
8.4.3 Shanghai Boyi Chemical Fruquintinib Product and Services
8.4.4 Shanghai Boyi Chemical Fruquintinib Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Shanghai Boyi Chemical Recent Developments/Updates
8.4.6 Shanghai Boyi Chemical Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Fruquintinib Industry Chain
9.2 Fruquintinib Upstream Analysis
9.2.1 Fruquintinib Core Raw Materials
9.2.2 Main Manufacturers of Fruquintinib Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Fruquintinib Production Mode
9.6 Fruquintinib Procurement Model
9.7 Fruquintinib Industry Sales Model and Sales Channels
9.7.1 Fruquintinib Sales Model
9.7.2 Fruquintinib Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Fruquintinib Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Fruquintinib Production Value by Region (2021-2026) & (USD Million)
Table 3. World Fruquintinib Production Value by Region (2027-2032) & (USD Million)
Table 4. World Fruquintinib Production Value Market Share by Region (2021-2026)
Table 5. World Fruquintinib Production Value Market Share by Region (2027-2032)
Table 6. World Fruquintinib Production by Region (2021-2026) & (Units)
Table 7. World Fruquintinib Production by Region (2027-2032) & (Units)
Table 8. World Fruquintinib Production Market Share by Region (2021-2026)
Table 9. World Fruquintinib Production Market Share by Region (2027-2032)
Table 10. World Fruquintinib Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Fruquintinib Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Fruquintinib Major Market Trends
Table 13. World Fruquintinib Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Fruquintinib Consumption by Region (2021-2026) & (Units)
Table 15. World Fruquintinib Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Fruquintinib Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Fruquintinib Producers in 2025
Table 18. World Fruquintinib Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Fruquintinib Producers in 2025
Table 20. World Fruquintinib Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Fruquintinib Company Evaluation Quadrant
Table 22. World Fruquintinib Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Fruquintinib Production Site of Key Manufacturer
Table 24. Fruquintinib Market: Company Product Type Footprint
Table 25. Fruquintinib Market: Company Product Application Footprint
Table 26. Fruquintinib Competitive Factors
Table 27. Fruquintinib New Entrant and Capacity Expansion Plans
Table 28. Fruquintinib Mergers & Acquisitions Activity
Table 29. United States VS China Fruquintinib Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Fruquintinib Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Fruquintinib Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Fruquintinib Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Fruquintinib Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Fruquintinib Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Fruquintinib Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Fruquintinib Production Market Share (2021-2026)
Table 37. China Based Fruquintinib Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Fruquintinib Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Fruquintinib Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Fruquintinib Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Fruquintinib Production Market Share (2021-2026)
Table 42. Rest of World Based Fruquintinib Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Fruquintinib Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Fruquintinib Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Fruquintinib Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Fruquintinib Production Market Share (2021-2026)
Table 47. World Fruquintinib Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Fruquintinib Production by Type (2021-2026) & (Units)
Table 49. World Fruquintinib Production by Type (2027-2032) & (Units)
Table 50. World Fruquintinib Production Value by Type (2021-2026) & (USD Million)
Table 51. World Fruquintinib Production Value by Type (2027-2032) & (USD Million)
Table 52. World Fruquintinib Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Fruquintinib Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Fruquintinib Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 55. World Fruquintinib Production by Sales Channels (2021-2026) & (Units)
Table 56. World Fruquintinib Production by Sales Channels (2027-2032) & (Units)
Table 57. World Fruquintinib Production Value by Sales Channels (2021-2026) & (USD Million)
Table 58. World Fruquintinib Production Value by Sales Channels (2027-2032) & (USD Million)
Table 59. World Fruquintinib Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 60. World Fruquintinib Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 61. World Fruquintinib Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Fruquintinib Production by Application (2021-2026) & (Units)
Table 63. World Fruquintinib Production by Application (2027-2032) & (Units)
Table 64. World Fruquintinib Production Value by Application (2021-2026) & (USD Million)
Table 65. World Fruquintinib Production Value by Application (2027-2032) & (USD Million)
Table 66. World Fruquintinib Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Fruquintinib Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Hutchison China MediTech Limited Basic Information, Manufacturing Base and Competitors
Table 69. Hutchison China MediTech Limited Major Business
Table 70. Hutchison China MediTech Limited Fruquintinib Product and Services
Table 71. Hutchison China MediTech Limited Fruquintinib Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Hutchison China MediTech Limited Recent Developments/Updates
Table 73. Hutchison China MediTech Limited Competitive Strengths & Weaknesses
Table 74. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 75. Takeda Pharmaceutical Company Limited Major Business
Table 76. Takeda Pharmaceutical Company Limited Fruquintinib Product and Services
Table 77. Takeda Pharmaceutical Company Limited Fruquintinib Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 79. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 80. Sichuan Qingmu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 81. Sichuan Qingmu Pharmaceutical Major Business
Table 82. Sichuan Qingmu Pharmaceutical Fruquintinib Product and Services
Table 83. Sichuan Qingmu Pharmaceutical Fruquintinib Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Sichuan Qingmu Pharmaceutical Recent Developments/Updates
Table 85. Sichuan Qingmu Pharmaceutical Competitive Strengths & Weaknesses
Table 86. Shanghai Boyi Chemical Basic Information, Manufacturing Base and Competitors
Table 87. Shanghai Boyi Chemical Major Business
Table 88. Shanghai Boyi Chemical Fruquintinib Product and Services
Table 89. Shanghai Boyi Chemical Fruquintinib Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Shanghai Boyi Chemical Recent Developments/Updates
Table 91. Shanghai Boyi Chemical Competitive Strengths & Weaknesses
Table 92. Global Key Players of Fruquintinib Upstream (Raw Materials)
Table 93. Global Fruquintinib Typical Customers
Table 94. Fruquintinib Typical Distributors
Table 1. World Fruquintinib Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Fruquintinib Production Value by Region (2021-2026) & (USD Million)
Table 3. World Fruquintinib Production Value by Region (2027-2032) & (USD Million)
Table 4. World Fruquintinib Production Value Market Share by Region (2021-2026)
Table 5. World Fruquintinib Production Value Market Share by Region (2027-2032)
Table 6. World Fruquintinib Production by Region (2021-2026) & (Units)
Table 7. World Fruquintinib Production by Region (2027-2032) & (Units)
Table 8. World Fruquintinib Production Market Share by Region (2021-2026)
Table 9. World Fruquintinib Production Market Share by Region (2027-2032)
Table 10. World Fruquintinib Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Fruquintinib Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Fruquintinib Major Market Trends
Table 13. World Fruquintinib Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Fruquintinib Consumption by Region (2021-2026) & (Units)
Table 15. World Fruquintinib Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Fruquintinib Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Fruquintinib Producers in 2025
Table 18. World Fruquintinib Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Fruquintinib Producers in 2025
Table 20. World Fruquintinib Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Fruquintinib Company Evaluation Quadrant
Table 22. World Fruquintinib Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Fruquintinib Production Site of Key Manufacturer
Table 24. Fruquintinib Market: Company Product Type Footprint
Table 25. Fruquintinib Market: Company Product Application Footprint
Table 26. Fruquintinib Competitive Factors
Table 27. Fruquintinib New Entrant and Capacity Expansion Plans
Table 28. Fruquintinib Mergers & Acquisitions Activity
Table 29. United States VS China Fruquintinib Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Fruquintinib Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Fruquintinib Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Fruquintinib Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Fruquintinib Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Fruquintinib Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Fruquintinib Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Fruquintinib Production Market Share (2021-2026)
Table 37. China Based Fruquintinib Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Fruquintinib Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Fruquintinib Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Fruquintinib Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Fruquintinib Production Market Share (2021-2026)
Table 42. Rest of World Based Fruquintinib Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Fruquintinib Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Fruquintinib Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Fruquintinib Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Fruquintinib Production Market Share (2021-2026)
Table 47. World Fruquintinib Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Fruquintinib Production by Type (2021-2026) & (Units)
Table 49. World Fruquintinib Production by Type (2027-2032) & (Units)
Table 50. World Fruquintinib Production Value by Type (2021-2026) & (USD Million)
Table 51. World Fruquintinib Production Value by Type (2027-2032) & (USD Million)
Table 52. World Fruquintinib Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Fruquintinib Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Fruquintinib Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 55. World Fruquintinib Production by Sales Channels (2021-2026) & (Units)
Table 56. World Fruquintinib Production by Sales Channels (2027-2032) & (Units)
Table 57. World Fruquintinib Production Value by Sales Channels (2021-2026) & (USD Million)
Table 58. World Fruquintinib Production Value by Sales Channels (2027-2032) & (USD Million)
Table 59. World Fruquintinib Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 60. World Fruquintinib Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 61. World Fruquintinib Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Fruquintinib Production by Application (2021-2026) & (Units)
Table 63. World Fruquintinib Production by Application (2027-2032) & (Units)
Table 64. World Fruquintinib Production Value by Application (2021-2026) & (USD Million)
Table 65. World Fruquintinib Production Value by Application (2027-2032) & (USD Million)
Table 66. World Fruquintinib Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Fruquintinib Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Hutchison China MediTech Limited Basic Information, Manufacturing Base and Competitors
Table 69. Hutchison China MediTech Limited Major Business
Table 70. Hutchison China MediTech Limited Fruquintinib Product and Services
Table 71. Hutchison China MediTech Limited Fruquintinib Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Hutchison China MediTech Limited Recent Developments/Updates
Table 73. Hutchison China MediTech Limited Competitive Strengths & Weaknesses
Table 74. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 75. Takeda Pharmaceutical Company Limited Major Business
Table 76. Takeda Pharmaceutical Company Limited Fruquintinib Product and Services
Table 77. Takeda Pharmaceutical Company Limited Fruquintinib Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 79. Takeda Pharmaceutical Company Limited Competitive Strengths & Weaknesses
Table 80. Sichuan Qingmu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 81. Sichuan Qingmu Pharmaceutical Major Business
Table 82. Sichuan Qingmu Pharmaceutical Fruquintinib Product and Services
Table 83. Sichuan Qingmu Pharmaceutical Fruquintinib Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Sichuan Qingmu Pharmaceutical Recent Developments/Updates
Table 85. Sichuan Qingmu Pharmaceutical Competitive Strengths & Weaknesses
Table 86. Shanghai Boyi Chemical Basic Information, Manufacturing Base and Competitors
Table 87. Shanghai Boyi Chemical Major Business
Table 88. Shanghai Boyi Chemical Fruquintinib Product and Services
Table 89. Shanghai Boyi Chemical Fruquintinib Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Shanghai Boyi Chemical Recent Developments/Updates
Table 91. Shanghai Boyi Chemical Competitive Strengths & Weaknesses
Table 92. Global Key Players of Fruquintinib Upstream (Raw Materials)
Table 93. Global Fruquintinib Typical Customers
Table 94. Fruquintinib Typical Distributors
LIST OF FIGURES
Figure 1. Fruquintinib Picture
Figure 2. World Fruquintinib Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Fruquintinib Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Fruquintinib Production (2021-2032) & (Units)
Figure 5. World Fruquintinib Average Price (2021-2032) & (US$/Unit)
Figure 6. World Fruquintinib Production Value Market Share by Region (2021-2032)
Figure 7. World Fruquintinib Production Market Share by Region (2021-2032)
Figure 8. North America Fruquintinib Production (2021-2032) & (Units)
Figure 9. Europe Fruquintinib Production (2021-2032) & (Units)
Figure 10. China Fruquintinib Production (2021-2032) & (Units)
Figure 11. Japan Fruquintinib Production (2021-2032) & (Units)
Figure 12. India Fruquintinib Production (2021-2032) & (Units)
Figure 13. Fruquintinib Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Fruquintinib Consumption (2021-2032) & (Units)
Figure 16. World Fruquintinib Consumption Market Share by Region (2021-2032)
Figure 17. United States Fruquintinib Consumption (2021-2032) & (Units)
Figure 18. China Fruquintinib Consumption (2021-2032) & (Units)
Figure 19. Europe Fruquintinib Consumption (2021-2032) & (Units)
Figure 20. Japan Fruquintinib Consumption (2021-2032) & (Units)
Figure 21. South Korea Fruquintinib Consumption (2021-2032) & (Units)
Figure 22. ASEAN Fruquintinib Consumption (2021-2032) & (Units)
Figure 23. India Fruquintinib Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Fruquintinib by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Fruquintinib Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Fruquintinib Markets in 2025
Figure 27. United States VS China: Fruquintinib Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Fruquintinib Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Fruquintinib Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Fruquintinib Production Market Share 2025
Figure 31. China Based Manufacturers Fruquintinib Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Fruquintinib Production Market Share 2025
Figure 33. World Fruquintinib Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Fruquintinib Production Value Market Share by Type in 2025
Figure 35. 1 mg capsule
Figure 36. 5 mg capsule
Figure 37. World Fruquintinib Production Market Share by Type (2021-2032)
Figure 38. World Fruquintinib Production Value Market Share by Type (2021-2032)
Figure 39. World Fruquintinib Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Fruquintinib Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 41. World Fruquintinib Production Value Market Share by Sales Channels in 2025
Figure 42. Hospital
Figure 43. Retail
Figure 44. Online
Figure 45. World Fruquintinib Production Market Share by Sales Channels (2021-2032)
Figure 46. World Fruquintinib Production Value Market Share by Sales Channels (2021-2032)
Figure 47. World Fruquintinib Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 48.Tablet
Figure 49. Capsule
Figure 50. World Fruquintinib Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Fruquintinib Production Value Market Share by Application in 2025
Figure 52. Metastatic Colorectal Cancer (mCRC)
Figure 53. Inhibit Tumor Angiogenesis
Figure 54. Others
Figure 55. World Fruquintinib Production Market Share by Application (2021-2032)
Figure 56. World Fruquintinib Production Value Market Share by Application (2021-2032)
Figure 57. World Fruquintinib Average Price by Application (2021-2032) & (US$/Unit)
Figure 58. Fruquintinib Industry Chain
Figure 59. Fruquintinib Procurement Model
Figure 60. Fruquintinib Sales Model
Figure 61. Fruquintinib Sales Channels, Direct Sales, and Distribution
Figure 62. Methodology
Figure 63. Research Process and Data Source
Figure 1. Fruquintinib Picture
Figure 2. World Fruquintinib Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Fruquintinib Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Fruquintinib Production (2021-2032) & (Units)
Figure 5. World Fruquintinib Average Price (2021-2032) & (US$/Unit)
Figure 6. World Fruquintinib Production Value Market Share by Region (2021-2032)
Figure 7. World Fruquintinib Production Market Share by Region (2021-2032)
Figure 8. North America Fruquintinib Production (2021-2032) & (Units)
Figure 9. Europe Fruquintinib Production (2021-2032) & (Units)
Figure 10. China Fruquintinib Production (2021-2032) & (Units)
Figure 11. Japan Fruquintinib Production (2021-2032) & (Units)
Figure 12. India Fruquintinib Production (2021-2032) & (Units)
Figure 13. Fruquintinib Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Fruquintinib Consumption (2021-2032) & (Units)
Figure 16. World Fruquintinib Consumption Market Share by Region (2021-2032)
Figure 17. United States Fruquintinib Consumption (2021-2032) & (Units)
Figure 18. China Fruquintinib Consumption (2021-2032) & (Units)
Figure 19. Europe Fruquintinib Consumption (2021-2032) & (Units)
Figure 20. Japan Fruquintinib Consumption (2021-2032) & (Units)
Figure 21. South Korea Fruquintinib Consumption (2021-2032) & (Units)
Figure 22. ASEAN Fruquintinib Consumption (2021-2032) & (Units)
Figure 23. India Fruquintinib Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Fruquintinib by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Fruquintinib Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Fruquintinib Markets in 2025
Figure 27. United States VS China: Fruquintinib Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Fruquintinib Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Fruquintinib Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Fruquintinib Production Market Share 2025
Figure 31. China Based Manufacturers Fruquintinib Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Fruquintinib Production Market Share 2025
Figure 33. World Fruquintinib Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Fruquintinib Production Value Market Share by Type in 2025
Figure 35. 1 mg capsule
Figure 36. 5 mg capsule
Figure 37. World Fruquintinib Production Market Share by Type (2021-2032)
Figure 38. World Fruquintinib Production Value Market Share by Type (2021-2032)
Figure 39. World Fruquintinib Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Fruquintinib Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 41. World Fruquintinib Production Value Market Share by Sales Channels in 2025
Figure 42. Hospital
Figure 43. Retail
Figure 44. Online
Figure 45. World Fruquintinib Production Market Share by Sales Channels (2021-2032)
Figure 46. World Fruquintinib Production Value Market Share by Sales Channels (2021-2032)
Figure 47. World Fruquintinib Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 48.Tablet
Figure 49. Capsule
Figure 50. World Fruquintinib Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Fruquintinib Production Value Market Share by Application in 2025
Figure 52. Metastatic Colorectal Cancer (mCRC)
Figure 53. Inhibit Tumor Angiogenesis
Figure 54. Others
Figure 55. World Fruquintinib Production Market Share by Application (2021-2032)
Figure 56. World Fruquintinib Production Value Market Share by Application (2021-2032)
Figure 57. World Fruquintinib Average Price by Application (2021-2032) & (US$/Unit)
Figure 58. Fruquintinib Industry Chain
Figure 59. Fruquintinib Procurement Model
Figure 60. Fruquintinib Sales Model
Figure 61. Fruquintinib Sales Channels, Direct Sales, and Distribution
Figure 62. Methodology
Figure 63. Research Process and Data Source
